Noveris Health Sciences is trading at CA$0.04, down 11.11%, with the cause of the November 9 move unclear. - No company-specific announcement or event explaining the decline surfaced; the latest surfaced company releases were earlier announcements. - The broader market is sharply higher, and available context does not establish a market-wide explanation. - No volume or trading-activity data was provided.